Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Study Information
Alliance Study ID: AFT-61
NCT Study ID (ClinicalTrials.gov): NCT07149363
Alliance Committee: Respiratory Cancer
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: Jacob Sands, MD; Chi-Fu Jeffrey Yang, MD
Status: RECRUITING
Study Description
This is a phase II trial of adjuvant chemotherapy and immunotherapy for completely resected small cell lung cancer (SCLC).
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Locations (3)
University of Illinois Chicago
Chicago, Illinois 60612
United States
Dana Farber Cancer Institute
Boston, Massachusetts 02215
United States
University of Virginia Comprehensive Cancer Center
Charlottesville, Virginia 22908
United States
Data Sources & Contacts
Full trial details
For more Information